Marksans Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve Audited Standalone and Consolidated ....
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Marksans Pharma has announced a board meeting on May 26, 2026 to consider and approve the audited financial results (standalone and consolidated) for Q4 and the full year ended March 31, 2026. The meeting will also consider dividend recommendations for FY 2025-26. The company has closed its trading window for designated persons from April 1, 2026 until 48 hours after the results announcement (up to May 28, 2026). This is a standard pre-result disclosure as required under SEBI listing regulations.
This is a routine board meeting notice for quarterly/annual results. The actual financial performance and any dividend decision will be known after May 26, 2026. Shareholders should await the official results announcement for material information.